CGS-15873

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCGS-15873
Drug Alias NameCGS-15873CGS-15873A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors agonistsSerotonin 1a (5-HT1a) receptor antagonistsAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2Dopamine receptorsSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsPsychotic DisordersParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsPsychotic DisordersParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A